Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate KinaseShow others and affiliations
2023 (English)In: Nutrients, E-ISSN 2072-6643, Vol. 15, no 3, p. 577-, article id 577
Article in journal (Refereed) Published
Abstract [en]
Liver pyruvate kinase (PKL) has recently emerged as a new target for non-alcoholic fatty liver disease (NAFLD), and inhibitors of this enzyme could represent a new therapeutic option. However, this breakthrough is complicated by selectivity issues since pyruvate kinase exists in four different isoforms. In this work, we report that ellagic acid (EA) and its derivatives, present in numerous fruits and vegetables, can inhibit PKL potently and selectively. Several polyphenolic analogues of EA were synthesized and tested to identify the chemical features responsible for the desired activity. Molecular modelling studies suggested that this inhibition is related to the stabilization of the PKL inactive state. This unique inhibition mechanism could potentially herald the development of new therapeutics for NAFLD.
Place, publisher, year, edition, pages
MDPI AG , 2023. Vol. 15, no 3, p. 577-, article id 577
Keywords [en]
NAFLD, liver pyruvate kinase, ellagic acid, urolithins, enzyme inhibition
National Category
Biochemistry Molecular Biology
Identifiers
URN: urn:nbn:se:kth:diva-324812DOI: 10.3390/nu15030577ISI: 000940885800001PubMedID: 36771285Scopus ID: 2-s2.0-85147362485OAI: oai:DiVA.org:kth-324812DiVA, id: diva2:1744973
Note
QC 20231122
2023-03-212023-03-212025-02-20Bibliographically approved